Industry: Medical Devices & Consumables
Published Date: 2026-04-17
Pages: 163 Pages
Report ld: 6020743
Request Sample
Customized Report
PTCA Dilatation Balloon Catheters Market Size(US$)

CAGR 2026-2032
8.9%
Market Size,2032
USD 2,516
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global PTCA Dilatation Balloon Catheters market was valued at US$ 1394 million in 2025 and is anticipated to reach US$ 2516 million by 2032, at a CAGR of 8.9% from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on PTCA Dilatation Balloon Catheters competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
PTCA dilatation balloon catheters are interventional medical devices used in the treatment of coronary artery stenosis, primarily during percutaneous coronary intervention (PCI) procedures. These catheters work by inflating a balloon at the lesion site to dilate the narrowed vessel and restore blood flow, often serving as preparation for stent implantation. Designed with a focus on compliance, flexibility, and inflation stability, they are widely applied in both pre-dilation and post-dilation phases. Based on their compliance characteristics, PTCA balloon catheters are classified into semi-compliant and non-compliant types to meet a variety of clinical needs.
Currently, PTCA dilatation balloon catheters are widely used in the global cardiovascular interventional field and serve as essential consumables in percutaneous coronary intervention (PCI) procedures. The market is dominated by major international medical device manufacturers, whose products are continually evolving in terms of compliance, folding technology, pushability, and radiopacity to meet the demands of complex lesions and precise vessel expansion. In recent years, as cardiovascular disease rates continue to rise and interventional healthcare infrastructure improves in developing countries, the global usage of PTCA balloon catheters has steadily increased, with expanding clinical application and a growing market footprint.
Looking forward, the trend toward minimally invasive and personalized medicine will drive further innovation in PTCA catheter design, focusing on lower profiles, higher pressure capabilities, and improved trackability to enhance procedural accuracy and address more challenging anatomies. Emerging innovations such as imaging-guided technology, drug-coated balloon integration, high-compliance materials, and controlled inflation features are expected to become key areas for product differentiation. In regions like Asia-Pacific, Latin America, and the Middle East, market penetration is projected to rise rapidly, supported by infrastructure development and a growing base of interventional cardiologists.
However, the market also faces several challenges. On one hand, the industry is experiencing increasing product homogenization and price competition, particularly under centralized procurement policies in certain regions, which compress profit margins. On the other hand, rising raw material costs, stricter regulatory oversight, and increasingly complex clinical approval processes for advanced devices are putting pressure on both R&D and compliance. Additionally, significant disparities in technical standards and registration requirements across countries are slowing the global expansion efforts of smaller and emerging manufacturers.
This report delivers a comprehensive overview of the global PTCA Dilatation Balloon Catheters market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding PTCA Dilatation Balloon Catheters. The PTCA Dilatation Balloon Catheters market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global PTCA Dilatation Balloon Catheters market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist PTCA Dilatation Balloon Catheters manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for PTCA Dilatation Balloon Catheters manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines PTCA Dilatation Balloon Catheters sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 PTCA Dilatation Balloon Catheters Market Overview
1.1 Product Definition
1.2 PTCA Dilatation Balloon Catheters by Type
1.2.1 Global PTCA Dilatation Balloon Catheters Market Value by Type: 2025 vs 2032
1.2.2 Semi-Compliant Type
1.2.3 Non-Compliant Type
1.3 PTCA Dilatation Balloon Catheters by Application
1.3.1 Global PTCA Dilatation Balloon Catheters Market Value by Application: 2025 vs 2032
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global PTCA Dilatation Balloon Catheters Market Size Estimates and Forecasts
1.4.1 Global PTCA Dilatation Balloon Catheters Revenue 2021–2032
1.4.2 Global PTCA Dilatation Balloon Catheters Sales 2021–2032
1.4.3 Global PTCA Dilatation Balloon Catheters Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 PTCA Dilatation Balloon Catheters Market Competition by Manufacturers
2.1 Global PTCA Dilatation Balloon Catheters Sales Market Share by Manufacturers (2021–2026)
2.2 Global PTCA Dilatation Balloon Catheters Revenue Market Share by Manufacturers (2021–2026)
2.3 Global PTCA Dilatation Balloon Catheters Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of PTCA Dilatation Balloon Catheters, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of PTCA Dilatation Balloon Catheters, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of PTCA Dilatation Balloon Catheters, Product Types and Applications
2.7 Global Key Manufacturers of PTCA Dilatation Balloon Catheters, Date of Entry into the Industry
2.8 Global PTCA Dilatation Balloon Catheters Market Competitive Situation and Trends
2.8.1 Global PTCA Dilatation Balloon Catheters Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global PTCA Dilatation Balloon Catheters Players Market Share by Revenue
2.8.3 Global PTCA Dilatation Balloon Catheters Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global PTCA Dilatation Balloon Catheters Market Scenario by Region
3.1 Global PTCA Dilatation Balloon Catheters Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global PTCA Dilatation Balloon Catheters Sales by Region: 2021–2032
3.2.1 Global PTCA Dilatation Balloon Catheters Sales by Region: 2021–2026
3.2.2 Global PTCA Dilatation Balloon Catheters Sales by Region: 2027–2032
3.3 Global PTCA Dilatation Balloon Catheters Revenue by Region: 2021–2032
3.3.1 Global PTCA Dilatation Balloon Catheters Revenue by Region: 2021–2026
3.3.2 Global PTCA Dilatation Balloon Catheters Revenue by Region: 2027–2032
3.4 North America PTCA Dilatation Balloon Catheters Market Facts & Figures by Country
3.4.1 North America PTCA Dilatation Balloon Catheters Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America PTCA Dilatation Balloon Catheters Sales by Country (2021–2032)
3.4.3 North America PTCA Dilatation Balloon Catheters Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe PTCA Dilatation Balloon Catheters Market Facts & Figures by Country
3.5.1 Europe PTCA Dilatation Balloon Catheters Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe PTCA Dilatation Balloon Catheters Sales by Country (2021–2032)
3.5.3 Europe PTCA Dilatation Balloon Catheters Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific PTCA Dilatation Balloon Catheters Market Facts & Figures by Region
3.6.1 Asia Pacific PTCA Dilatation Balloon Catheters Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific PTCA Dilatation Balloon Catheters Sales by Region (2021–2032)
3.6.3 Asia Pacific PTCA Dilatation Balloon Catheters Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America PTCA Dilatation Balloon Catheters Market Facts & Figures by Country
3.7.1 Latin America PTCA Dilatation Balloon Catheters Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America PTCA Dilatation Balloon Catheters Sales by Country (2021–2032)
3.7.3 Latin America PTCA Dilatation Balloon Catheters Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa PTCA Dilatation Balloon Catheters Market Facts & Figures by Country
3.8.1 Middle East and Africa PTCA Dilatation Balloon Catheters Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa PTCA Dilatation Balloon Catheters Sales by Country (2021–2032)
3.8.3 Middle East and Africa PTCA Dilatation Balloon Catheters Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global PTCA Dilatation Balloon Catheters Sales by Type (2021–2032)
4.1.1 Global PTCA Dilatation Balloon Catheters Sales by Type (2021–2026)
4.1.2 Global PTCA Dilatation Balloon Catheters Sales by Type (2027–2032)
4.1.3 Global PTCA Dilatation Balloon Catheters Sales Market Share by Type (2021–2032)
4.2 Global PTCA Dilatation Balloon Catheters Revenue by Type (2021–2032)
4.2.1 Global PTCA Dilatation Balloon Catheters Revenue by Type (2021–2026)
4.2.2 Global PTCA Dilatation Balloon Catheters Revenue by Type (2027–2032)
4.2.3 Global PTCA Dilatation Balloon Catheters Revenue Market Share by Type (2021–2032)
4.3 Global PTCA Dilatation Balloon Catheters Price by Type (2021–2032)
5 Segment by Application
5.1 Global PTCA Dilatation Balloon Catheters Sales by Application (2021–2032)
5.1.1 Global PTCA Dilatation Balloon Catheters Sales by Application (2021–2026)
5.1.2 Global PTCA Dilatation Balloon Catheters Sales by Application (2027–2032)
5.1.3 Global PTCA Dilatation Balloon Catheters Sales Market Share by Application (2021–2032)
5.2 Global PTCA Dilatation Balloon Catheters Revenue by Application (2021–2032)
5.2.1 Global PTCA Dilatation Balloon Catheters Revenue by Application (2021–2026)
5.2.2 Global PTCA Dilatation Balloon Catheters Revenue by Application (2027–2032)
5.2.3 Global PTCA Dilatation Balloon Catheters Revenue Market Share by Application (2021–2032)
5.3 Global PTCA Dilatation Balloon Catheters Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Boston Scientific
6.1.1 Boston Scientific Company Information
6.1.2 Boston Scientific Description and Business Overview
6.1.3 Boston Scientific PTCA Dilatation Balloon Catheters Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Boston Scientific PTCA Dilatation Balloon Catheters Product Portfolio
6.1.5 Boston Scientific Recent Developments/Updates
6.2 Abbott
6.2.1 Abbott Company Information
6.2.2 Abbott Description and Business Overview
6.2.3 Abbott PTCA Dilatation Balloon Catheters Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Abbott PTCA Dilatation Balloon Catheters Product Portfolio
6.2.5 Abbott Recent Developments/Updates
6.3 Medtronic
6.3.1 Medtronic Company Information
6.3.2 Medtronic Description and Business Overview
6.3.3 Medtronic PTCA Dilatation Balloon Catheters Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Medtronic PTCA Dilatation Balloon Catheters Product Portfolio
6.3.5 Medtronic Recent Developments/Updates
6.4 Terumo
6.4.1 Terumo Company Information
6.4.2 Terumo Description and Business Overview
6.4.3 Terumo PTCA Dilatation Balloon Catheters Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Terumo PTCA Dilatation Balloon Catheters Product Portfolio
6.4.5 Terumo Recent Developments/Updates
6.5 Bluesail
6.5.1 Bluesail Company Information
6.5.2 Bluesail Description and Business Overview
6.5.3 Bluesail PTCA Dilatation Balloon Catheters Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Bluesail PTCA Dilatation Balloon Catheters Product Portfolio
6.5.5 Bluesail Recent Developments/Updates
6.6 B. Braun
6.6.1 B. Braun Company Information
6.6.2 B. Braun Description and Business Overview
6.6.3 B. Braun PTCA Dilatation Balloon Catheters Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 B. Braun PTCA Dilatation Balloon Catheters Product Portfolio
6.6.5 B. Braun Recent Developments/Updates
6.7 Acrostak
6.7.1 Acrostak Company Information
6.7.2 Acrostak Description and Business Overview
6.7.3 Acrostak PTCA Dilatation Balloon Catheters Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Acrostak PTCA Dilatation Balloon Catheters Product Portfolio
6.7.5 Acrostak Recent Developments/Updates
6.8 KANEKA
6.8.1 KANEKA Company Information
6.8.2 KANEKA Description and Business Overview
6.8.3 KANEKA PTCA Dilatation Balloon Catheters Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 KANEKA PTCA Dilatation Balloon Catheters Product Portfolio
6.8.5 KANEKA Recent Developments/Updates
6.9 GENOSS
6.9.1 GENOSS Company Information
6.9.2 GENOSS Description and Business Overview
6.9.3 GENOSS PTCA Dilatation Balloon Catheters Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 GENOSS PTCA Dilatation Balloon Catheters Product Portfolio
6.9.5 GENOSS Recent Developments/Updates
6.10 Biotronik
6.10.1 Biotronik Company Information
6.10.2 Biotronik Description and Business Overview
6.10.3 Biotronik PTCA Dilatation Balloon Catheters Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Biotronik PTCA Dilatation Balloon Catheters Product Portfolio
6.10.5 Biotronik Recent Developments/Updates
6.11 Translumina
6.11.1 Translumina Company Information
6.11.2 Translumina Description and Business Overview
6.11.3 Translumina PTCA Dilatation Balloon Catheters Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Translumina PTCA Dilatation Balloon Catheters Product Portfolio
6.11.5 Translumina Recent Developments/Updates
6.12 Alvimedica
6.12.1 Alvimedica Company Information
6.12.2 Alvimedica Description and Business Overview
6.12.3 Alvimedica PTCA Dilatation Balloon Catheters Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Alvimedica PTCA Dilatation Balloon Catheters Product Portfolio
6.12.5 Alvimedica Recent Developments/Updates
6.13 Cordis
6.13.1 Cordis Company Information
6.13.2 Cordis Description and Business Overview
6.13.3 Cordis PTCA Dilatation Balloon Catheters Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Cordis PTCA Dilatation Balloon Catheters Product Portfolio
6.13.5 Cordis Recent Developments/Updates
6.14 Balton
6.14.1 Balton Company Information
6.14.2 Balton Description and Business Overview
6.14.3 Balton PTCA Dilatation Balloon Catheters Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 Balton PTCA Dilatation Balloon Catheters Product Portfolio
6.14.5 Balton Recent Developments/Updates
6.15 Hexacath
6.15.1 Hexacath Company Information
6.15.2 Hexacath Description and Business Overview
6.15.3 Hexacath PTCA Dilatation Balloon Catheters Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 Hexacath PTCA Dilatation Balloon Catheters Product Portfolio
6.15.5 Hexacath Recent Developments/Updates
6.16 InSitu Technologies
6.16.1 InSitu Technologies Company Information
6.16.2 InSitu Technologies Description and Business Overview
6.16.3 InSitu Technologies PTCA Dilatation Balloon Catheters Sales, Revenue, and Gross Margin (2021–2026)
6.16.4 InSitu Technologies PTCA Dilatation Balloon Catheters Product Portfolio
6.16.5 InSitu Technologies Recent Developments/Updates
6.17 Teleflex
6.17.1 Teleflex Company Information
6.17.2 Teleflex Description and Business Overview
6.17.3 Teleflex PTCA Dilatation Balloon Catheters Sales, Revenue, and Gross Margin (2021–2026)
6.17.4 Teleflex PTCA Dilatation Balloon Catheters Product Portfolio
6.17.5 Teleflex Recent Developments/Updates
6.18 MicroPort
6.18.1 MicroPort Company Information
6.18.2 MicroPort Description and Business Overview
6.18.3 MicroPort PTCA Dilatation Balloon Catheters Sales, Revenue, and Gross Margin (2021–2026)
6.18.4 MicroPort PTCA Dilatation Balloon Catheters Product Portfolio
6.18.5 MicroPort Recent Developments/Updates
6.19 APT Medical
6.19.1 APT Medical Company Information
6.19.2 APT Medical Description and Business Overview
6.19.3 APT Medical PTCA Dilatation Balloon Catheters Sales, Revenue, and Gross Margin (2021–2026)
6.19.4 APT Medical PTCA Dilatation Balloon Catheters Product Portfolio
6.19.5 APT Medical Recent Developments/Updates
6.20 BrosMed Medical
6.20.1 BrosMed Medical Company Information
6.20.2 BrosMed Medical Description and Business Overview
6.20.3 BrosMed Medical PTCA Dilatation Balloon Catheters Sales, Revenue, and Gross Margin (2021–2026)
6.20.4 BrosMed Medical PTCA Dilatation Balloon Catheters Product Portfolio
6.20.5 BrosMed Medical Recent Developments/Updates
6.21 OrbusNeich Medical
6.21.1 OrbusNeich Medical Company Information
6.21.2 OrbusNeich Medical Description and Business Overview
6.21.3 OrbusNeich Medical PTCA Dilatation Balloon Catheters Sales, Revenue, and Gross Margin (2021–2026)
6.21.4 OrbusNeich Medical PTCA Dilatation Balloon Catheters Product Portfolio
6.21.5 OrbusNeich Medical Recent Developments/Updates
6.22 Lepu Medical
6.22.1 Lepu Medical Company Information
6.22.2 Lepu Medical Description and Business Overview
6.22.3 Lepu Medical PTCA Dilatation Balloon Catheters Sales, Revenue, and Gross Margin (2021–2026)
6.22.4 Lepu Medical PTCA Dilatation Balloon Catheters Product Portfolio
6.22.5 Lepu Medical Recent Developments/Updates
6.23 Shunmei Medical
6.23.1 Shunmei Medical Company Information
6.23.2 Shunmei Medical Description and Business Overview
6.23.3 Shunmei Medical PTCA Dilatation Balloon Catheters Sales, Revenue, and Gross Margin (2021–2026)
6.23.4 Shunmei Medical PTCA Dilatation Balloon Catheters Product Portfolio
6.23.5 Shunmei Medical Recent Developments/Updates
6.24 Shanghai INT Medical
6.24.1 Shanghai INT Medical Company Information
6.24.2 Shanghai INT Medical Description and Business Overview
6.24.3 Shanghai INT Medical PTCA Dilatation Balloon Catheters Sales, Revenue, and Gross Margin (2021–2026)
6.24.4 Shanghai INT Medical PTCA Dilatation Balloon Catheters Product Portfolio
6.24.5 Shanghai INT Medical Recent Developments/Updates
6.25 Sinomed
6.25.1 Sinomed Company Information
6.25.2 Sinomed Description and Business Overview
6.25.3 Sinomed PTCA Dilatation Balloon Catheters Sales, Revenue, and Gross Margin (2021–2026)
6.25.4 Sinomed PTCA Dilatation Balloon Catheters Product Portfolio
6.25.5 Sinomed Recent Developments/Updates
6.26 Nanjing YDB Medical
6.26.1 Nanjing YDB Medical Company Information
6.26.2 Nanjing YDB Medical Description and Business Overview
6.26.3 Nanjing YDB Medical PTCA Dilatation Balloon Catheters Sales, Revenue, and Gross Margin (2021–2026)
6.26.4 Nanjing YDB Medical PTCA Dilatation Balloon Catheters Product Portfolio
6.26.5 Nanjing YDB Medical Recent Developments/Updates
6.27 Zhejiang Barty Medical
6.27.1 Zhejiang Barty Medical Company Information
6.27.2 Zhejiang Barty Medical Description and Business Overview
6.27.3 Zhejiang Barty Medical PTCA Dilatation Balloon Catheters Sales, Revenue, and Gross Margin (2021–2026)
6.27.4 Zhejiang Barty Medical PTCA Dilatation Balloon Catheters Product Portfolio
6.27.5 Zhejiang Barty Medical Recent Developments/Updates
6.28 Medoo Medical
6.28.1 Medoo Medical Company Information
6.28.2 Medoo Medical Description and Business Overview
6.28.3 Medoo Medical PTCA Dilatation Balloon Catheters Sales, Revenue, and Gross Margin (2021–2026)
6.28.4 Medoo Medical PTCA Dilatation Balloon Catheters Product Portfolio
6.28.5 Medoo Medical Recent Developments/Updates
6.29 Yinyi Biotech
6.29.1 Yinyi Biotech Company Information
6.29.2 Yinyi Biotech Description and Business Overview
6.29.3 Yinyi Biotech PTCA Dilatation Balloon Catheters Sales, Revenue, and Gross Margin (2021–2026)
6.29.4 Yinyi Biotech PTCA Dilatation Balloon Catheters Product Portfolio
6.29.5 Yinyi Biotech Recent Developments/Updates
6.30 HengYi Medical
6.30.1 HengYi Medical Company Information
6.30.2 HengYi Medical Description and Business Overview
6.30.3 HengYi Medical PTCA Dilatation Balloon Catheters Sales, Revenue, and Gross Margin (2021–2026)
6.30.4 HengYi Medical PTCA Dilatation Balloon Catheters Product Portfolio
6.30.5 HengYi Medical Recent Developments/Updates
6.31 Demax Medical
6.31.1 Demax Medical Company Information
6.31.2 Demax Medical Description and Business Overview
6.31.3 Demax Medical PTCA Dilatation Balloon Catheters Sales, Revenue, and Gross Margin (2021–2026)
6.31.4 Demax Medical PTCA Dilatation Balloon Catheters Product Portfolio
6.31.5 Demax Medical Recent Developments/Updates
6.32 DK Medical Technology
6.32.1 DK Medical Technology Company Information
6.32.2 DK Medical Technology Description and Business Overview
6.32.3 DK Medical Technology PTCA Dilatation Balloon Catheters Sales, Revenue, and Gross Margin (2021–2026)
6.32.4 DK Medical Technology PTCA Dilatation Balloon Catheters Product Portfolio
6.32.5 DK Medical Technology Recent Developments/Updates
6.33 SCW Medicath
6.33.1 SCW Medicath Company Information
6.33.2 SCW Medicath Description and Business Overview
6.33.3 SCW Medicath PTCA Dilatation Balloon Catheters Sales, Revenue, and Gross Margin (2021–2026)
6.33.4 SCW Medicath PTCA Dilatation Balloon Catheters Product Portfolio
6.33.5 SCW Medicath Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 PTCA Dilatation Balloon Catheters Industry Chain Analysis
7.2 PTCA Dilatation Balloon Catheters Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 PTCA Dilatation Balloon Catheters Production Mode & Process Analysis
7.4 PTCA Dilatation Balloon Catheters Sales and Marketing
7.4.1 PTCA Dilatation Balloon Catheters Sales Channels
7.4.2 PTCA Dilatation Balloon Catheters Distributors
7.5 PTCA Dilatation Balloon Catheters Customer Analysis
8 PTCA Dilatation Balloon Catheters Market Dynamics
8.1 PTCA Dilatation Balloon Catheters Industry Trends
8.2 PTCA Dilatation Balloon Catheters Market Drivers
8.3 PTCA Dilatation Balloon Catheters Market Challenges
8.4 PTCA Dilatation Balloon Catheters Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global PTCA Dilatation Balloon Catheters market size was US$ 1394 million in 2025 and is forecast to reach a readjusted size of US$ 2516 million by 2032 with a CAGR of 8.9% during the forecast period 2026-2032.
Published Date: 2026-03-09
Pages: 139
USD 4250.00
(Single User License)
The global market for PTCA Dilatation Balloon Catheters was estimated to be worth US$ 1394 million in 2025 and is projected to reach US$ 2516 million, growing at a CAGR of 8.9% from 2026 to 2032.
Published Date: 2026-03-06
Pages: 226
USD 3950.00
(Single User License)
The global PTCA Dilatation Balloon Catheters market size was US$ 1312 million in 2024 and is forecast to a readjusted size of US$ 2329 million by 2031 with a CAGR of 8.9% during the forecast period 2025-2031.
Published Date: 2025-11-02
Pages: 142
USD 4250.00
(Single User License)
The global PTCA Dilatation Balloon Catheters market is projected to grow from US$ 1312 million in 2024 to US$ 2329 million by 2031, at a CAGR of 8.9% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-02
Pages: 225
USD 4900.00
(Single User License)
The global market for PTCA Dilatation Balloon Catheters was estimated to be worth US$ 1312 million in 2024 and is forecast to a readjusted size of US$ 2329 million by 2031 with a CAGR of 8.9% during the forecast period 2025-2031.
Published Date: 2025-07-24
Pages: 194
USD 3950.00
(Single User License)
The global market for PTCA Dilatation Balloon Catheters was valued at US$ 1312 million in the year 2024 and is projected to reach a revised size of US$ 2329 million by 2031, growing at a CAGR of 8.9% during the forecast period.
Published Date: 2025-07-24
Pages: 143
USD 2900.00
(Single User License)
The global market for PTCA Dilatation Balloon Catheters was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-01-13
Pages: 139
USD 3950.00
(Single User License)
PTCA Dilatation Balloon Catheter is intended for balloon dilatation of a hemodynamically significant coronary artery or bypass graft stenosis in patients evidencing coronary ischemia for the purpose of improving myocardial perfusion.
Published Date: 2024-01-17
Pages: 114
USD 2900.00
(Single User License)
The global PTCA Dilatation Balloon Catheters market size was US$ 1394 million in 2025 and is forecast to reach a readjusted size of US$ 2516 million by 2032 with a CAGR of 8.9% during the forecast period 2026-2032.
Published: 2026-03-09
Pages: 139
The global market for PTCA Dilatation Balloon Catheters was estimated to be worth US$ 1394 million in 2025 and is projected to reach US$ 2516 million, growing at a CAGR of 8.9% from 2026 to 2032.
Published: 2026-03-06
Pages: 226
The global PTCA Dilatation Balloon Catheters market size was US$ 1312 million in 2024 and is forecast to a readjusted size of US$ 2329 million by 2031 with a CAGR of 8.9% during the forecast period 2025-2031.
Published: 2025-11-02
Pages: 142
The global PTCA Dilatation Balloon Catheters market is projected to grow from US$ 1312 million in 2024 to US$ 2329 million by 2031, at a CAGR of 8.9% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-02
Pages: 225
The global market for PTCA Dilatation Balloon Catheters was estimated to be worth US$ 1312 million in 2024 and is forecast to a readjusted size of US$ 2329 million by 2031 with a CAGR of 8.9% during the forecast period 2025-2031.
Published: 2025-07-24
Pages: 194
The global market for PTCA Dilatation Balloon Catheters was valued at US$ 1312 million in the year 2024 and is projected to reach a revised size of US$ 2329 million by 2031, growing at a CAGR of 8.9% during the forecast period.
Published: 2025-07-24
Pages: 143
The global market for PTCA Dilatation Balloon Catheters was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-01-13
Pages: 139
PTCA Dilatation Balloon Catheter is intended for balloon dilatation of a hemodynamically significant coronary artery or bypass graft stenosis in patients evidencing coronary ischemia for the purpose of improving myocardial perfusion.
Published: 2024-01-17
Pages: 114
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now